S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
NASDAQ:TKNO

Alpha Teknova (TKNO) Stock Price, News & Analysis

$2.65
+0.19 (+7.72%)
(As of 03/28/2024 ET)
Today's Range
$2.40
$2.72
50-Day Range
$2.41
$3.53
52-Week Range
$1.62
$4.27
Volume
15,480 shs
Average Volume
7,093 shs
Market Capitalization
$107.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
TKNO stock logo

About Alpha Teknova Stock (NASDAQ:TKNO)

Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.

TKNO Stock Price History

TKNO Stock News Headlines

Bombshell 2024 election documentary
2024: America’s Last Election New documentary reveals why this could be America’s Last Election… and how the elites’ plan threatens to reset the entire U.S. economy, along with your 401(k), bank, and stock portfolio.
Recap: Alpha Teknova Q4 Earnings
Earnings Preview: Alpha Teknova
Bombshell 2024 election documentary
2024: America’s Last Election New documentary reveals why this could be America’s Last Election… and how the elites’ plan threatens to reset the entire U.S. economy, along with your 401(k), bank, and stock portfolio.
Alpha Teknova Insiders Land Bargain With Gains Of US$1.4m
Alpha Teknova: Q3 Earnings Insights
Alpha Teknova Inc TKNO
Teknova Announces New Board Member, Martha J. Demski
Teknova Reports Second Quarter 2023 Financial Results
See More Headlines
Receive TKNO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alpha Teknova and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/09/2021
Today
3/29/2024
Next Earnings (Estimated)
5/08/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostic substances
Sub-Industry
N/A
Current Symbol
NASDAQ:TKNO
Fax
N/A
Employees
285
Year Founded
N/A

Profitability

Net Income
$-36,780,000.00
Net Margins
-100.26%
Pretax Margin
-109.53%

Debt

Sales & Book Value

Annual Sales
$36.68 million
Book Value
$3.56 per share

Miscellaneous

Free Float
34,537,000
Market Cap
$107.93 million
Optionable
Not Optionable
Beta
0.25
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

TKNO Stock Analysis - Frequently Asked Questions

Should I buy or sell Alpha Teknova stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Alpha Teknova in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" TKNO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TKNO, but not buy additional shares or sell existing shares.
View TKNO analyst ratings
or view top-rated stocks.

How have TKNO shares performed in 2024?

Alpha Teknova's stock was trading at $3.73 on January 1st, 2024. Since then, TKNO stock has decreased by 29.0% and is now trading at $2.65.
View the best growth stocks for 2024 here
.

When is Alpha Teknova's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our TKNO earnings forecast
.

How were Alpha Teknova's earnings last quarter?

Alpha Teknova, Inc. (NASDAQ:TKNO) released its quarterly earnings results on Tuesday, November, 9th. The company reported ($0.12) earnings per share for the quarter, meeting the consensus estimate of ($0.12). The firm had revenue of $9.39 million for the quarter, compared to analyst estimates of $8 million. Alpha Teknova had a negative net margin of 100.26% and a negative trailing twelve-month return on equity of 37.85%.

What guidance has Alpha Teknova issued on next quarter's earnings?

Alpha Teknova issued an update on its FY 2024 earnings guidance on Tuesday, March, 12th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $35.0 million-$38.0 million, compared to the consensus revenue estimate of $41.5 million.

When did Alpha Teknova IPO?

Alpha Teknova (TKNO) raised $90 million in an initial public offering (IPO) on Friday, June 25th 2021. The company issued 6,000,000 shares at a price of $14.00-$16.00 per share.

Who are Alpha Teknova's major shareholders?

Alpha Teknova's stock is owned by many different retail and institutional investors. Top institutional investors include Balyasny Asset Management L.P. (3.55%), Platinum Investment Management Ltd. (2.50%), Vanguard Group Inc. (1.34%), Vanguard Group Inc. (0.97%), Parkman Healthcare Partners LLC (0.96%) and Conestoga Capital Advisors LLC (0.84%). Insiders that own company stock include Damon Terrill, J Matthew Mackowski, Ken Gelhaus, Lisa Hood, Matthew Lowell, Stephen Gunstream, Ted Davis and Telegraph Hill Partners Iv, L.
View institutional ownership trends
.

How do I buy shares of Alpha Teknova?

Shares of TKNO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TKNO) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners